In 2016, more than 27,000 adults in the US will be diagnosed with multiple myeloma (MM). Although MM remains an incurable disease, the encouraging news is that between 2000 and 2009 there was a 73% increase in survivors. However, despite recent advances, MM continues to be a challenge for health care professionals to control. Because MM displays considerable heterogeneity, loss of control of the disease in the form of relapse is becoming more commonplace. To counteract this, newer management approaches such as collaborative practice, risk strategy, and individualized therapy are essential.
Thus, JADPRO—Journal of the Advanced Practitioner in Oncology presents Multiple Myeloma Updates, a monthly educational newsletter. Editorial content will be provided by practicing physicians, physician assistants, nurse practitioners, and pharmacists with expertise in the diagnosis and management of MM. I hope you find this to be a useful resource in your practice!
Beth Faiman, PhD, APN-BC, AOCN
Multiple Myeloma Program
Taussig Cancer Institute